| Enriched cancer pathway | Genes under regulation | P value |
|---|
| RNA degradation |
9 genes: DDX6, ENO2, CNOT1, PAN3, CNOT3, CNOT4, XRN1, CNOT6, BTG2
|
0.0001945 |
| Hippo signaling pathway |
13 genes: MPP5, CDH1, RASSF6, PPP2R2D, PPP1CB, DLG2, BMP7, ID2, FZD3, DVL3, APC, TCF7L2, CCND1
|
0.0005275 |
| Regulation of actin cytoskeleton |
13 genes: ABI2, VAV3, DOCK1, FGFR2, ARHGEF12, APC, PFN2, PPP1CB, ENAH, MAPK1, GNG12, TIAM1, CDC42
|
0.009349 |
| Melanogenesis |
7 genes: DVL3, GNAS, KIT, MAPK1, TCF7L2, FZD3, CAMK2G
|
0.02673 |
| Neurotrophin signaling pathway |
8 genes: FRS2, PRDM4, AKT2, IRS1, MAPK1, PTPN11, CAMK2G, CDC42
|
0.03068 |
| TGF.beta signaling pathway |
6 genes: ID2, SMAD5, MAPK1, BMP7, ACVR1, ZFYVE16
|
0.03596 |
| RNA polymerase |
3 genes: POLR3A, POLR2J2, POLR2J3
|
0.04989 |